Advertisement

Wiener klinische Wochenschrift

, Volume 119, Issue 19–20, pp 602–608 | Cite as

Surgical aspects of gastrinoma in multiple endocrine neoplasia type 1

  • Detlef K. Bartsch
  • Peter Langer
  • Matthias Rothmund
Article

Summary

Gastrinoma is the most frequent functional pancreatioduodenal endocrine tumor in patients with multilpe endocrine neoplasia type 1 (MEN1) and one major determinant of mortality in this syndrome. Whether routine surgical exploration should be performed in a patient with MEN1 associated Zollinger-Ellison syndrome (ZES) to possibly reduce the malignant spread and eventually increase survival still remains controversial. There is not only disagreement about the indication for surgical exploration, but also what type of procedure should be performed, since sufficient evidence-based data are not available. The article discusses the available data on treatment strategies of MEN1 associated ZES.

Keywords

MEN1 Gastrinoma ZES Surgery 

Chirurgische Aspekte des Gastrinoms bei der Multiplen endokrinen Neoplasie Typ 1

Zusammenfassung

Das Gastrinom ist der häufigste funktionell aktive pankrearticoduodenale Tumor bei Patienten mit einer Multiplen endokrinen Neoplasie Typ 1 und eine der Haupttodesursachen dieses Syndroms. Ob eine routinemäßige chirurgische Exploration bei Patienten mit nachgewiesenem MEN1-assoziierten Zollinger-Ellison-Syndrom (ZES) durchgeführt werden sollte, wird kontrovers gesehen. Da evidenz-basierte Daten feheln, besteht derzeit auch Uneinigkeit über die durchzuführende operative Prozedur. Dieser Artikel diskutiert die verfügbaren Daten zu möglichen Therapiestrategien beim MEN1-assozierten ZES.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Wermer P (1954) Genetic aspects of adenomatosis of endocrine glands. Am J Med 16: 363–371PubMedCrossRefGoogle Scholar
  2. Chandrasekharappa SC, Guru SC, Manickamp P, Olufemi SE, Collins FS, Emmert-Buck MR, et al (1997) Positional cloning of the gene for multiple endocrine neoplasia type 1 (MEN1). Science 276: 404–407PubMedCrossRefGoogle Scholar
  3. Gobl AE, Berg M, Lopez-Egido JR, Oberg K, Skogseid B, Westin G (1999) Menin represses JunD-activated transcription by a histone deacetylase-dependent mechanism. Biochim Biophys Acta 1447: 51–56PubMedGoogle Scholar
  4. Lips CJM, Vasen HFA, Lamers CBH (1984) Multiple endocrine neoplasia syndromes. Crit Rev Oncol Hematol 2: 117–184PubMedCrossRefGoogle Scholar
  5. Vasen HFA, Lamers CBH, Lips CJM (1989) Screening for the multiple endocrine neoplasia syndrome: a study of 11 kindreds in the Netherlands. Arch Inter Med 149: 2717–2721CrossRefGoogle Scholar
  6. Langer P, Wild A, Nies C, Rothmund M, Bartsch DK (2001) Variable expression of multiple endocrine neoplasia type 1 – implications for screening strategies. Int J Surg Invest 3: 473–481Google Scholar
  7. Marx SJ, Vinik AI, Santen RJ, Floyd JC Jr, ills JL, Green J 3rd (1986) Multiple endocrine neoplasia type 1: assessment of labarotory tests to screen for the gene in a large kindred. Medicine 65: 226–241PubMedCrossRefGoogle Scholar
  8. Skogseid BS, Eriksson B, Lundqvist G, Lorelius LE, Rastad J, Wide L, Akerstrom G, Oberg K (1991) Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab1 73: 281–287Google Scholar
  9. Anlauf M, Perren A, Meyer CL, Schmid S, Saremaslani P, Kruse ML, et al (2005) Precursor lesions in patients with multiple endocrine neoplasia type 1-associated duodenal gastrinomas. Gastroenterology 128: 1187–1198PubMedCrossRefGoogle Scholar
  10. Norton JA, Fraker DL, Alexander HR, Venzon DJ, Doppman JL, Serrano J, et al (1999) Surgery to cure the Zollinger-Elisson syndrome. N Engl J Med 341: 635–644PubMedCrossRefGoogle Scholar
  11. Weber HC, Venzon DJ, Lin JT, Fishbein VA, Orbuch M, Strader DB, et al (1995) Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology 108: 1637–1649PubMedCrossRefGoogle Scholar
  12. Yu F, Venzon DJ, Serrano J, Goebel SU, Doppman JL, Gibril F, Jensen RT (1999) Prospective study of the clinical course, prognostic factors, cause of death, and survival in patients with long-standing Zollinger-Elisson syndrome. J Clin Oncol 17: 615–630PubMedGoogle Scholar
  13. Norton JA, Jensen RT (2003) Current surgical management of Zollinger-Elisson sndrome in patients without multiple endocrine neoplasia type 1. Surg Oncol 12: 145–151PubMedCrossRefGoogle Scholar
  14. Gibril F, Venzon DJ, Ojeaburu JV, Bashir S, Jensen RT (2001) Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonagressive form. J Clin Endocrinol Metab 86: 5282–5293PubMedCrossRefGoogle Scholar
  15. Norton JA, Cornelius MJ, Doppmann JL, Maton PN, Garner JD, Jensen RT (1987) Effect of parathyroidectomy in patients with hyperparathyroidism, Zolllinger-Ellison syndrome and multiple endocrine neoplasia type 1; a prospective study. Surgery 102: 958PubMedGoogle Scholar
  16. Oberg K, Skogseid B (1998) The ultimate biochemical diagnosis of endocrine pancreatic tumours in MEN-1. J Int Med 243: 471–476CrossRefGoogle Scholar
  17. Skogseid B, Oberg K, Benson L, Lindgren PG, Lorelius LE, Lundquist G, Wide L, Wilander E (1987) A standardised meal stimulation test of the endocrine pancreas for early detection of pancreatic endocrine tumours in multiple endocrine neoplasia type 1 syndrome: five years experience. J Clin Endocrinol Metab 64: 1233–1240PubMedGoogle Scholar
  18. Langer P, Wild A, Celik I, Kopp I, Bergenfelz A, Bartsch DK (2001) Prospective controlled trial of a standardised meal stimulation test in the detection of pancreaticoduodenal endocrine tumours in patients with multiple endocrine neoplasia type 1. Br J Surg 88: 1403–1407PubMedCrossRefGoogle Scholar
  19. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, et al (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86: 5658–5671PubMedCrossRefGoogle Scholar
  20. Kwekkeboom D, Krenning EP, de Jong M (2000) Peptide receptor imaging and therapy. J Nucl Med 41: 1704–1713PubMedGoogle Scholar
  21. Gibril F, Reynolds JC, Doppman JL, Chen CC, Venzon DJ, Termanini B, et al (1997) Somatostain receptor scintigraphy: its sensitivity compared with that of imaging methods in detecting primary and metastatic gastrinomas: a prospective study. Ann Intern Med 125: 26–34Google Scholar
  22. Alexander HR, Fraker DL, Norton JA, Bartlett DL, Tio L, Benjamin SB, et al (1998) Porspective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Elisson syndrome. Ann Surg 228: 228–238PubMedCrossRefGoogle Scholar
  23. Anderson MA, Carpenter S, Thompson NW, Nostrant TT, Elta GH, Scheiman JM (2000) Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol 95: 2271–2277PubMedCrossRefGoogle Scholar
  24. Gauger PG, Scheiman JM, Wamsteker E-J, Richards ML, Doherty GM, Thompson NW (2003) Role of endoscopic ultrasonography in screening and treatment of pancreatic endocrine tumours in asymptomatic patients with multiple endocrine neoplasia type 1. Br J Surg 90: 748–754PubMedCrossRefGoogle Scholar
  25. Kann PH, Wirkus B, Keth A, Goitom K (2003) Pitfalls in endosonographic imaging of suspected insulinomas: pancreatic nodules of unknown dignity. Eur J Endocrinol 148: 531–534PubMedCrossRefGoogle Scholar
  26. Langer P, Kann PH, Fendrich V, Richter G, Diehl S, Rothmund M, Bartsch DK (2004) Prospective evaluation of imaging procedures for the detection of pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1. World J Surg 28: 1317–1322PubMedCrossRefGoogle Scholar
  27. Imamura M, Takahashi K, Adachi H (1976) Usefulness of selective arterial secretin injection test for localization of gastrinoma in the Zollinger-Ellison syndrome. Ann Surg 76: 205–230Google Scholar
  28. Kisker O, Bastian D, Bartsch D, Nies C, Rothmund M (1998) Localisation, malignant potential, and surgical management of gastrinoma. World J Surg 22: 651–658PubMedCrossRefGoogle Scholar
  29. Thompson NW (1998) Management of pancreatic endocrine tumors in patients with multiple endocrine neoplasia type 1. Surg Clin N Am 7: 881–891Google Scholar
  30. Cadiot G, Vuagnat A, Doukhan I, Murat A, Bonnaud G, Delemer B, et al (1999) Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d'Etude des Neoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE). Gastroenterology 116: 286–293PubMedCrossRefGoogle Scholar
  31. Jensen RT (1998) Management of Zollinger-Elisson syndrome in patients with multiple endocrine neoplasia type 1. J Intern Med 243: 477–488PubMedCrossRefGoogle Scholar
  32. Norton JA, Alexander HR, Fraker DL, Venzon DJ, Gibril F, Jensen RT, Fraker DL (2001) Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome. Ann Surg 234: 495–505PubMedCrossRefGoogle Scholar
  33. Malagelada JR, Edis AJ, Adson MA, van Heerden JA, Go VL (1983) Medical and surgical options in the management of patients with gastrinoma. Gastroenterology 84: 1524–1532PubMedGoogle Scholar
  34. Mignon M, Cadiot G (1998) Diagnostic and therapeutic criteria in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. J Intern Med 243: 489–494PubMedCrossRefGoogle Scholar
  35. Mac Farlane MP, Fraker DL, Alexander HR, Norton JA, Lubensyk I, Jensen RT (1995) Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1. Surgery 118: 973–979CrossRefGoogle Scholar
  36. Norton JA, Wells SA Jr (1997) The surgical management of patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 82: 359–361CrossRefGoogle Scholar
  37. Bartsch DK, Langer P, Wild A, Schilling T, Celik I, Rothmund M, Nies C (2000) Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? Surgery 128: 958–966PubMedCrossRefGoogle Scholar
  38. Akerstrom G, Hessman O, Skogseid B (2002) Timing and extent of surgery in symptomatic and asymptomatic neuroendocrine tumors of the pancreas in MEN1. Langenbecks Arch Surg 386: 558–569PubMedCrossRefGoogle Scholar
  39. Wilkinson S, Teh BT, Davey KR, McArdle JP, Young M, Shepherd JJ (1993) Cause of death in multiple endocrine neoplasia type 1. Arch Surg 128: 683–690PubMedGoogle Scholar
  40. Doherty GM, Doherty GM, Olson JA, Frisella MM, Lairmore TC, Wells SA Jr, Norton JA (1998) Lethality of multiple endocrine neoplasia type 1. World J Surg 22: 581–587PubMedCrossRefGoogle Scholar
  41. Gibril F, Schumann M, Pace A, Jensen RT (2004) Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome. A prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine 83: 43–83PubMedCrossRefGoogle Scholar
  42. Fraker DL, Norton JA, Alexander R, Venzon DJ, Jensen RT (1994) Surgery for Zollinger-Ellison syndrome alters the natural history of gastrinoma. Ann Surg 220: 320–330PubMedCrossRefGoogle Scholar
  43. Lowney JK, Frisella MM, Lairmore TC, Doherty GM (1999) Pancreatic islet cell tumor metastasis in multiple endocrine neoplasia type 1: correlation with primary tumor size. Surgery 125: 1043–1049Google Scholar
  44. Bartsch DK, Fendrich V, Langer P, Celik I, Kann PH, Rothmund M (2005) Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. Ann Surg 6: 757–766CrossRefGoogle Scholar
  45. Skogseid B, Öberg K, Eriksson B, Juhlin C, Granberg D, Akerstrom G, Rastad J (1996) Surgery for asymptomatic pancreatic lesions in multiple endocrine neoplasia type 1. World J Surg 20: 872–877PubMedCrossRefGoogle Scholar
  46. Kouvaraki MA, Lee JES, Shapiro SE (2002) Genotypephenotype analysis in multiple endocrine neoplasia type 1. Arch Surg 137: 641–647PubMedCrossRefGoogle Scholar
  47. Hausman MS Jr, Thompson NW, Gauger PG, Doherty GM (2004) The surgical management of MEN-1 pancreatoduodenal neuroendocrine disease. Surgery 136: 1205–1211PubMedCrossRefGoogle Scholar
  48. Skogseid BS, Eriksson B, Lundqvist G, Lorelius LE, Rastad J, Wide L, Akerstrom G, Oberg K (1991) Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab 73: 281–287PubMedCrossRefGoogle Scholar
  49. Gauger PG, Thompson NW (2001) Early surgical intervention and strategy in patients with multiple endocrine neoplasia type 1. Best Pract Res Clin Endocrinol Metab 15: 213–223PubMedCrossRefGoogle Scholar
  50. Pipeleers-Marichal M, Somers G, Willems G, Foulis A, Imrie C, Bishop AE, et al (1990) Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome. N Engl J Med 322: 723–727PubMedCrossRefGoogle Scholar
  51. Imamura M, Komoto I, Doi R, Onodera H, Kobayashi H, Kawai Y (2005) New pancreas-preserving total duodenectomy technique. World J Surg 29: 203–207PubMedCrossRefGoogle Scholar
  52. Langer P, Bartsch DK, Fendrich V, Kann PH, Rothmund M, Zielke A (2005) Minimal-invasive operative treatment of organic hyperinsulinism. Dtsch Med Wochenschr 130: 514–518PubMedCrossRefGoogle Scholar
  53. Fernandez-Cruz L, Saenz A, Astudillo E, Martinez I, Hoyos S, Pantoja JP, Navarro S (2002) Outcome of laparoscopic pancreatic surgery: endocrine and nonendocrine tumors. World J Surg 26: 1057–1065PubMedCrossRefGoogle Scholar
  54. Blanc P, Porcheron J, Pages A, Breton C, Mosnier JF, Balique JG (2000) Laparoscopic excicion of a duodenal neuroendocrine tumor. Ann Chir 125: 176–178PubMedCrossRefGoogle Scholar
  55. Stabile BE, Morrow DJ, Passaro E Jr (1984) The gastrinoma triangle: operative implications. Am J Surg 147: 25–31PubMedCrossRefGoogle Scholar
  56. Norton JA, Jensen RT (2004) Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome. Ann Surg 240: 757–773PubMedCrossRefGoogle Scholar
  57. Jaskowiak NT, Fraker DL, Alexander HR, Norton JA, Doppmann JL, Jensen RT (1996) Is reoperation for gastrinoma excision in Zollinger-Elisson syndrome indicated? Surgery 120: 1057–1063CrossRefGoogle Scholar
  58. Mignon M, Ruszniewski P, Podevin P, Sabbagh L, Cadiot G, Rigaud D, Bonfils S (1993) Current approach to the management of gastrinoma and insulinoma in adults with multiple endocrine neoplasia type 1. World J Surg 17: 489–497PubMedCrossRefGoogle Scholar
  59. Grama D, Eriksson B, Martensson H, Cedermark B, Ahren B, Kristoffersson A, Rastad J, Oberg K, Akerstrom G (1992) Clinical characteristics, treatment and survival in patients with pancreatic tumors causing hormonal syndromes. World J Surg 16: 632–639PubMedCrossRefGoogle Scholar
  60. MacFarlane MP, Fraker DL, Alexander HR, Norton JA, Lubensky I, Jensen RT (1995) Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1. Surgery 118: 973–979PubMedCrossRefGoogle Scholar
  61. Delcore R, Friesen SR (1992) Role of pancreatoduodenectomy in the management of primary duodenal wall gastrinomas in patients with Zollinger-Ellison syndrome. Surgery 112: 1016–1022PubMedGoogle Scholar
  62. Stadil F (1995) Treatment of gastrinomas with pancreatoduodenectomy. In: Mignon M, Jensen RT (eds) Endocrine tumors of the pancreas: recent advances in research and management. Vol 23 of Frontiers of gastrointestinal research. Karger Basel, Switzerland, pp 333–337Google Scholar
  63. Schroder W, Holscher AH, Beckurts T, Richter TH, Hofler H, Siewert JR (1996) Duodenal microgastrinomas associated with Zollinger-Ellison syndrome. Hepatogastroenterology 43: 1465–1469PubMedGoogle Scholar
  64. Kato M, Imamura M, Hosotani R, Shimada Y, Doi R, Itami A, et al (2000) Curative resection of microgastrinomas based on the intraoperative secretin test. World J Surg 24: 1425–1430PubMedCrossRefGoogle Scholar
  65. Lairmore TC, Chen VY, DeBenedetti MK, Gillanders WE, Norton JA, Doherty GM (2000) Duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. Ann Surg 231: 909–918PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Detlef K. Bartsch
    • 1
  • Peter Langer
    • 2
  • Matthias Rothmund
    • 2
  1. 1.Klinik für Allgemein- und Viszeralchirurgie der Städt. Kliniken Bielefeld-MitteBielefeldGermany
  2. 2.Klinik für Visceral-, Thorax- und Gefäßchirurgie der Universität Marburg-GießenMarburgGermany

Personalised recommendations